A
Aelis Farma SA
PAR:AELIS
Aelis Farma SA
PAR:AELIS
Price:
1.322
EUR
0.92%
Market Closed
Market Cap:
€18.1m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Aelis Farma SA
PAR:AELIS
|
FR |
|
NuGene International Inc
OTC:NUGN
|
US |
|
Metalart Corp
TSE:5644
|
JP |
|
Jagran Prakashan Ltd
NSE:JAGRAN
|
IN |
|
Prologue SA
PAR:ALPRG
|
FR |
|
S
|
Sif Holding NV
AEX:SIFG
|
NL |
|
K
|
KGHM Polska Miedz SA
OTC:KGHPF
|
PL |
|
Y
|
Yarrl SA
WSE:YRL
|
PL |
|
C
|
Celestica Inc
NYSE:CLS
|
CA |
|
S
|
Sta Lucia Land Inc
XPHS:SLI
|
PH |
|
D
|
Delfingen Industry SA
XBER:HBS
|
FR |
|
H
|
Hon Hai Precision Industry Co Ltd
LSE:HHPD
|
TW |
|
ISC Business Technology AG
F:I5Q1
|
CH |
|
Itausa SA
BOVESPA:ITSA4
|
BR |
|
S
|
Sun Life Financial Inc
NYSE:SLF
|
CA |
|
V
|
Vonovia SE
OTC:VNNVF
|
DE |
|
Baozun Inc
NASDAQ:BZUN
|
CN |
|
Alpen Co Ltd
TSE:3028
|
JP |
|
Asra Minerals Ltd
ASX:ASR
|
AU |
|
Diaceutics PLC
LSE:DXRX
|
UK |
|
H
|
Hefei Chipmore Technology Co Ltd
SSE:688352
|
CN |
|
S
|
SKF India Ltd
BSE:500472
|
IN |
|
V
|
Vrain Solution Inc
TSE:135A
|
JP |
|
Intergis Co Ltd
KRX:129260
|
KR |
Cash Flow Statement
Cash Flow Statement
Aelis Farma SA
Aelis Farma SA
Currency: EUR
| Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||
| Net Income |
1
|
(14)
|
(14)
|
(6)
|
(5)
|
(7)
|
(7)
|
(8)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
3
|
7
|
7
|
0
|
1
|
2
|
2
|
2
|
|
| Cash Taxes Paid |
1
|
1
|
2
|
2
|
1
|
1
|
2
|
1
|
|
| Cash Interest Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Change in Working Capital |
15
|
(7)
|
(6)
|
(8)
|
(9)
|
(9)
|
(7)
|
(2)
|
|
| Cash from Operating Activities |
19
N/A
|
(14)
N/A
|
(13)
+5%
|
(13)
+3%
|
(13)
-2%
|
(13)
-1%
|
(12)
+10%
|
(8)
+36%
|
|
| Investing Cash Flow | |||||||||
| Capital Expenditures |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(0)
N/A
|
(0)
-57%
|
(0)
+59%
|
0
N/A
|
(0)
N/A
|
(0)
-258%
|
(0)
+40%
|
(0)
+84%
|
|
| Financing Cash Flow | |||||||||
| Net Issuance of Common Stock |
0
|
23
|
23
|
0
|
0
|
0
|
4
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
2
|
2
|
|
| Other |
0
|
(0)
|
(1)
|
(1)
|
(1)
|
1
|
(1)
|
(0)
|
|
| Cash from Financing Activities |
0
N/A
|
23
+12 659%
|
22
-4%
|
(1)
N/A
|
(1)
+26%
|
1
N/A
|
6
+939%
|
6
+1%
|
|
| Change in Cash | |||||||||
| Effect of Foreign Exchange Rates |
1
|
2
|
1
|
(0)
|
(0)
|
(0)
|
0
|
(0)
|
|
| Net Change in Cash |
20
N/A
|
11
-48%
|
10
-8%
|
(14)
N/A
|
(14)
+1%
|
(13)
+9%
|
(6)
+52%
|
(2)
+71%
|
|
| Free Cash Flow | |||||||||
| Free Cash Flow |
19
N/A
|
(14)
N/A
|
(13)
+6%
|
(13)
+3%
|
(13)
-2%
|
(13)
-2%
|
(12)
+10%
|
(8)
+37%
|
|
Switch to:
Switch to:
See Also
Discover More
